On Tuesday morning, a significant number of prominent companies disclosed their earnings, showcasing a diverse range of performances against Wall Street’s projections, as indicated by Bloomberg consensus estimates. Notable among these companies was Novartis, which reported adjusted basic earnings per share (EPS) of $2.06, surpassing the expected $1.94. Additionally, the pharmaceutical giant generated a revenue...
Premium Membership Required
You must be a Premium member to access this content.
Already a member? Log in here